Skip to Content
MilliporeSigma
All Photos(8)

Key Documents

793574

Sigma-Aldrich

Sodium bromide

anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
NaBr
CAS Number:
Molecular Weight:
102.89
EC Number:
MDL number:
UNSPSC Code:
12352302
PubChem Substance ID:
NACRES:
NA.21

assay:
≥99%
grade:
ACS reagent
anhydrous
form:
powder
Pricing and availability is not currently available.

grade

ACS reagent
anhydrous

Quality Level

vapor pressure

1 mmHg ( 806 °C)

product line

Redi-Dri

assay

≥99%

form

powder

quality

free-flowing

impurities

≤0.005% insolubles

pH

5.0-8.8 (25 °C, 5%)

mp

755 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
310506220345229881
form

powder

form

powder, crystals or granules

form

powder or crystals

form

crystalline

assay

≥99%

assay

≥99.0%

assay

≥99%

assay

≥99.99% trace metals basis

Quality Level

200

Quality Level

200

Quality Level

100

Quality Level

100

grade

ACS reagent, anhydrous

grade

ACS reagent

grade

-

grade

-

pH

5.0-8.8 (25 °C, 5%)

pH

5.0-8.8 (25 °C, 5%)

pH

5.4 (20 °C, 50 g/L)

pH

-

mp

755 °C (lit.)

mp

755 °C (lit.)

mp

755 °C (lit.)

mp

755 °C (lit.)

General description

Sodium bromide (NaBr) is an inorganic salt. It is an inexpensive source of bromide anion. It is used as a nucleophilic catalyst in organic synthesis. Additionally, NaBr is a useful electrolyte in electrochemical oxidations.

Application


  • Sensitive and Low-Noise Perovskite Nanocrystal-Organic Bulk Heterostructure X-ray Detectors Enabled by Sodium Bromide-Assisted In Situ Reparation: This research underscores the role of sodium bromide in enhancing the fabrication of perovskite nanocrystals for advanced X-ray detection technologies, illustrating its utility in high-precision imaging applications critical for both medical and industrial use (Li Y, Fang Y, 2024).

  • Surface-Modified Carboxylated Cellulose Nanofiber Hydrogels for Prolonged Release of Polyhexamethylene Biguanide Hydrochloride (PHMB) for Antimicrobial Applications: Demonstrates the effectiveness of sodium bromide in modifying cellulose nanofibers for use in sustained drug release systems, highlighting its importance in the development of antimicrobial materials (O-Chongpian P, Jantrawut P, 2023).

  • Unravelling Alkali-Metal-Assisted Domain Distribution of Quasi-2D Perovskites for Cascade Energy Transfer toward Efficient Blue Light-Emitting Diodes: Details the utilization of sodium bromide in the synthesis of quasi-2D perovskites, paving the way for improvements in blue light-emitting diode (LED) technology which is crucial for display and lighting solutions (Cai W, Yip HL, 2022).

  • Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism: Highlights the potential therapeutic applications of sodium bromide in neuropsychiatric disorders, providing insights into its efficacy in alleviating symptoms of autism within experimental settings (Derieux C, Becker JAJ, 2022).

  • Development of Flexible Plasticized Ion Conducting Polymer Blend Electrolytes Based on Polyvinyl Alcohol (PVA): Chitosan (CS) with High Ion Transport Parameters Close to Gel Based Electrolytes: Showcases the role of sodium bromide in the development of high-performance polymer electrolytes for energy storage applications, demonstrating its impact on enhancing ion transport properties (Sadiq NM, Kadir MFZ, 2022).

Legal Information

Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

pictograms

Health hazardExclamation mark

signalword

Warning

Hazard Classifications

Repr. 2 - STOT RE 2 - STOT SE 3

target_organs

Central nervous system

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


  • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Jinxiang Yuan et al.
    Journal of virology, 89(24), 12284-12298 (2015-10-02)
    Triggers and regulatory pathways that effectively link human cytomegalovirus (HCMV) major immediate early (MIE) latent-lytic switch activation with progeny production are incompletely understood. In the quiescently infected human NTera2 cell model of primitive neural stem cells, we found that costimulation
    Ganna Galitska et al.
    Frontiers in immunology, 12, 532484-532484 (2021-04-27)
    Human cytomegalovirus (HCMV) infection often leads to systemic disease in immunodeficient patients and congenitally infected children. Despite its clinical significance, the exact mechanisms contributing to HCMV pathogenesis and clinical outcomes have yet to be determined. One of such mechanisms involves
    Melissa Galinato et al.
    Frontiers in microbiology, 10, 577-577 (2019-04-06)
    Myeloid cells are important sites of lytic and latent infection by human cytomegalovirus (CMV). We previously showed that only a small subset of myeloid cells differentiated from CD34+ hematopoietic stem cells is permissive to CMV replication, underscoring the heterogeneous nature
    Ramona Businger et al.
    mBio, 12(4), e0177021-e0177021 (2021-08-18)
    The plasma membrane (PM) must be overcome by viruses during entry and release. Furthermore, the PM represents the cellular communication compartment and the immune system interface. Hence, viruses have evolved sophisticated strategies to remodel the PM, for instance to avoid
    Ozan S Kumru et al.
    Vaccine, 37(44), 6696-6706 (2019-09-25)
    Live attenuated viral vaccine/vector candidates are inherently unstable and infectivity titer losses can readily occur without defining appropriate formulations, storage conditions and clinical handling practices. During initial process development of a candidate vaccine against HIV-1 using a recombinant Human Cytomegalovirus

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service